HPS-114 - Efficacy and safety of colchicine on adverse cardiovascular outcomes in patients with myocardial infarction: A systematic review

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HPS-114
• By: YANG, Hsinyu (Far Eastern Memorial Hospital, China Taiwan)
• Co-author(s): Ms Hsinyu Yang (Far Eastern Memorial Hospital, New Taipei city, China Taiwan)
  Ms TairShin Wang (Far Eastern Memorial Hospital, New Taipei city, China Taiwan)
  Mr MingShyan Wang (Far Eastern Memorial Hospital, New Taipei city, China Taiwan)
  
• Abstract:

  Inflammation may play an important role in acute coronary syndrome and stable coronary artery disease that contributes to post-Myocardial infarction (MI) prognosis. The 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline provided a class 2b recommendation for the use of colchicine, an anti-inflammatory agent, in patients after acute coronary syndrome...

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login